Caroline Truntzer Selected Research

Caroline Truntzer Research Topics

Disease

38	Neoplasms (Cancer) 01/2024 - 07/2010
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2019
7	Breast Neoplasms (Breast Cancer) 06/2023 - 01/2018
5	Neoplasm Metastasis (Metastasis) 04/2023 - 05/2018
4	Glioblastoma (Glioblastoma Multiforme) 05/2024 - 10/2016
4	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 11/2018
3	Genomic Instability 03/2022 - 08/2021
3	Ovarian Neoplasms (Ovarian Cancer) 02/2022 - 08/2020
3	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2022
3	Lung Neoplasms (Lung Cancer) 01/2019 - 11/2018
2	Brain Neoplasms (Brain Tumor) 05/2024 - 01/2023
2	Carcinoma (Carcinomatosis) 02/2022 - 08/2021
2	Melanoma (Melanoma, Malignant) 01/2022 - 08/2020
2	COVID-19 01/2022 - 01/2021
2	Adenocarcinoma 04/2021 - 05/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2020 - 05/2018
1	Triple Negative Breast Neoplasms 06/2023
1	Turcot syndrome 04/2023
1	Infections 01/2022
1	Carcinogenesis 01/2022
1	Oncogene Addiction 11/2021
1	Hypertension (High Blood Pressure) 10/2020
1	Heart Failure 10/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 08/2020
1	Prostatic Neoplasms (Prostate Cancer) 08/2020
1	Disease Progression 08/2020
1	Endometrial Neoplasms (Endometrial Cancer) 08/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020
1	Splenomegaly 05/2018
1	Glaucoma 10/2017
1	Gliosis 10/2017

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 10/2023 - 07/2010
13	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2019
3	RNA (Ribonucleic Acid)IBA 10/2023 - 10/2018
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2023 - 08/2020
3	Programmed Cell Death 1 ReceptorIBA 01/2023 - 01/2020
3	atezolizumabIBA 10/2022 - 01/2019
3	LigandsIBA 01/2022 - 01/2020
3	AntibodiesIBA 01/2022 - 01/2021
3	Monoclonal AntibodiesIBA 06/2021 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 02/2023 - 03/2022
2	PlatinumIBA 02/2023 - 03/2022
2	tremelimumabIBA 01/2023 - 08/2020
2	durvalumabIBA 01/2023 - 08/2020
2	Bevacizumab (Avastin)FDA Link 12/2022 - 10/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2022
2	folfirinoxIBA 04/2021 - 05/2018
2	NivolumabIBA 01/2019 - 01/2019
2	LipidsIBA 10/2017 - 01/2016
1	Pyruvate KinaseIBA 10/2023
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2023
1	SaltsIBA 02/2023
1	trastuzumab deruxtecanIBA 01/2023
1	tucatinibIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Cell Adhesion Molecule-1IBA 01/2023
1	Netrin-1IBA 01/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2022
1	SuspensionsIBA 10/2022
1	nintedanibIBA 02/2022
1	Carboplatin (JM8)FDA LinkGeneric 02/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Cancer VaccinesIBA 01/2022
1	Pemetrexed (MTA)FDA Link 01/2022
1	B7-H1 AntigenIBA 01/2022
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	Interleukin-4 (Interleukin 4)IBA 01/2022
1	CytokinesIBA 01/2022
1	Chemokine CCL20IBA 01/2022
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 01/2022
1	Chemokine CXCL10IBA 01/2022
1	Diacylglycerol O-AcyltransferaseIBA 01/2022
1	Protein Kinase InhibitorsIBA 01/2022
1	NucleotidesIBA 11/2021
1	AntigensIBA 11/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 08/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 10/2020
1	olaparibIBA 08/2020
1	IpilimumabIBA 01/2019
1	pembrolizumabIBA 01/2019
1	Galectins (Galectin)IBA 01/2019
1	Calbindin 2IBA 01/2018
1	24-hydroxycholesterolIBA 10/2017
1	Retinaldehyde (Retinal)IBA 10/2017
1	CholesterolIBA 10/2017

Therapy/Procedure

18	Therapeutics 01/2024 - 10/2018
10	Immunotherapy 05/2024 - 10/2018
8	Drug Therapy (Chemotherapy) 01/2023 - 11/2018
3	Chemoradiotherapy 05/2024 - 10/2016
2	Neoadjuvant Therapy 11/2022 - 11/2018
2	Precision Medicine 08/2020 - 11/2018
1	Adjuvant Chemotherapy 01/2024